CD59 is a glycosyl-phosphatidylinositol (GPI)-anchored cell membrane glycoprotein that inhibits complement-mediated cell lysis by preventing full assembly of the membrane attack complex (MAC) on host cells, and thus might confer immune resistance to tumor cells [42]. The gene discussed is CD59; the disease is neoplasm.